BPR-3-K-007-S-0

N/A

Report date: 2026/05/08 20:02:52
NME

Base Information

Drug NameBPR-3-K-007-S-0
Drug Alias NameBPR3K007S0BPR-3-K-007-S-0
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEpidermal growth factor receptor erbB1 inhibitors
TargetsEpidermal growth factor receptor erbB1
Therapy Area/IndicationsHead and Neck Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesNational Health Research Institutes
China Registration ClassN/A

Develop Information

Active CompaniesNational Health Research Institutes
Inactive CompaniesN/A
Active IndicationsHead and Neck Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A